CDA and breast carcinoma: We analyzed CDA mRNA and protein activity levels in blood samples from BC patients with a suspected predisposition to breast cancer (BC), and from healthy volunteers as controls, to determine whether a constitutive CDA deficiency might underlie some breast cancers.